Streptokinase in the management of arterial thrombosis in infancy

C. R. Kirk, S. A. Qureshi

Research output: Contribution to journalArticle

20 Scopus citations

Abstract

Fourteen children with a mean age of 9.7 months (range 0.1-34.0 months) and a mean weight of 5.4 kg (range 2.5-10.0 kg) received intravenous streptokinase following arterial thrombosis. A median loading dose of 1000 U/kg (range 750-4000 U/kg) was given followed by an initial median infusion rate of 1000 U/kg/hr (range 750-1000 U/kg/hr). If thrombolysis did not occur and the fibrinogen level remained within the normal range (1.5-4.5 g/l) the infusion rate was increased to a maximum of 3000 U/kg/hr. Thrombolysis was achieved in all cases a mean of 16.7 hours (range 2-44 hours) after the start of treatment. The mean fibrinogen level at thrombolysis was 1.11 g/l (range 0.28-2.25 g/l) compared with pretreatment levels of 2.12 g/l (range 1.4-3.05 g/l). Minor bleeding from arterial puncture sites occurred in 6 children (43%). Streptokinase is a safe and effective treatment for arterial thrombosis in children.

Original languageEnglish (US)
Pages (from-to)15-20
Number of pages6
JournalInternational Journal of Cardiology
Volume25
Issue number1
DOIs
StatePublished - Oct 1989

Keywords

  • Arterial thrombosis
  • Streptokinase
  • Thrombolysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Streptokinase in the management of arterial thrombosis in infancy'. Together they form a unique fingerprint.

  • Cite this